Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Hypnose til at forbedre velvære hos kritisk syge patienter og forebygge post-intensivsygeplejesyndrom (HypnoPICS)

9. november 2026 opdateret af: COEN Matteo

Hypnose til at forbedre trivsel hos kritisk syge patienter og forebygge post-intensivsygeplejesyndrom

The goal of this clinical trial is to evaluate the effectiveness of a hypnosis intervention in improving well-being at day 28 of an ICU stay. The main question it aims to answer is :

-Does Hypnosis intervention at ICU discharge and on day 7 and 14 on the wards if the patient remains in the hospital, improve wellbeing at 28 days ?

Researchers will compare discharged ICU patients who received standard post-discharge care to discharged ICU patients who received standard post-discharge care and hypnosis intervention on discharge and 7 and 14days after if they are still in the hospital, to see if hypnosis can improve their wellbeing.

Participants will receive a hypnosis session on the day of ICU discharge, a second session seven days post-discharge and a third session at day 14 if they are still in the hospital.

Studieoversigt

Status

Rekruttering

Intervention / Behandling

Detaljeret beskrivelse

Critically ill patients in the Intensive Care Unit (ICU) face numerous challenges both acutely and in the long term. These patients frequently experience acute pain and anxiety due to intubation and induced comas. Following their ICU discharge, they commonly report decreased well-being and quality of life. Additionally, up to 40% of critically ill patients develop post-intensive care syndrome (PICS), which includes mental, physical, and cognitive sequelae that can persist up to one year after discharge. Heavy sedation and medications necessary to manage pain and anxiety are known risk factors for PICS.

The current standard of care in the ICU includes mobilization and nutrition, pain control, and family engagement and empowerment. Furthermore, no other specific interventions are aimed at improving long-term outcomes and preventing PICS.

Several studies have explored using hypnosis to improve the acute care of ICU patients. For instance, a pain protocol that included hypnosis in burn patients hospitalized in the CHUV (Centre Hospitalier Universitaire Vaudois) resulted in reduced pain intensity, reduced opioid use, reduced anxiety, and better wound outcomes, all while lowering costs. A pilot study involving non-invasive ventilation patients showed that hypnosis could improve comfort, mask tolerance, and anxiety levels. Additionally, studies on relaxation therapy have indicated that electronic relaxation therapy is a promising, safe, and effective non-pharmacological solution to enhance overall comfort in alert and non-delirious ICU patients.

However, despite these efforts, there is a lack of efficient interventions specifically targeting the wellbeing of patients after an ICU stay and the prevention of PICS. Existing interventions, such as follow-up programs, rehabilitation, and psychological follow-up, have shown conflicting results. To date, no studies have specifically assessed the effect of hypnosis on the short and longer-term well-being of critically ill patients leaving the ICU and its possible effect on the prevention of PICS.

The investigators hypothesize that providing a hypnosis session at ICU discharge and followed by subsequent sessions on days 7 and 14 on the ward will improve well-being in the short term and reduce PICS symptoms at 3-months. The primary outcome will be the assessment of well-being at day 28 post-ICU discharge. Secondary outcomes will be anxiety, depression, PTSD, and quality of life at three months.

Hypothesis and primary objective The investigators hypothesize that providing intervention with hypnosis at ICU discharge and subsequent sessions on day 7 and 14 on the ward if the patient remains in the hospital will improve wellbeing at day 28 and reduce PICS symptoms at three months in critically ill patients.

Primary Objective:

The primary objective of this study is to evaluate the effectiveness of a hypnosis intervention in improving well-being at day 28 of an ICU stay.

Scale used for wellbeing:

  • ESAS, total 90, each item on a 0-10 scale
  • EQ-5D-5L

Secondary Objectives:

  1. To assess the impact of a hypnosis intervention to improve PICS at 3 months

    • Anxiety and depression: PHQ-9 et GAD-7
    • Post-traumatic stress disorder: PDI and IES-R scale
    • Quality of life: SF-12, EQ-5D-5L and WHODAS 2.0
    • Patient impression of change: PGIC
  2. To evaluate patient immediate wellbeing after the hypnosis intervention. • ESAS before after the session in patients who will get the session

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

150

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Undersøgelse Kontakt Backup

  • Navn: Jennifer B. C. S Muradbegovic, Doctor
  • Telefonnummer: +41 79 55 36255
  • E-mail: jennifer.cau@hug.ch

Studiesteder

      • Geneva, Schweiz, 1205
        • Rekruttering
        • University Hospital of Geneva
        • Kontakt:
        • Kontakt:
      • Neuchâtel, Schweiz
        • Ikke rekrutterer endnu
        • Hôpitaux Neuchâtelois
        • Kontakt:
          • Marie-Eve Brunner, Medical Doctor

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • On Mechanical Ventilation for at least 2 days
  • Able to give informed consent as documented by signature
  • French speaking

Exclusion Criteria:

  • Refusal of the patient
  • Patient transferred from another ICU
  • Patient is planned for a withdrawal of care or is actively dying
  • Glasgow coma scale (GCS) <15 on ICU discharge
  • Patient presenting with delirium (detected by CAM-ICU) on ICU discharge
  • Patient hospitalized for traumatic brain injury
  • Patient is in jail
  • Patient hospitalized for more than 28 days in the ICU

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Forebyggelse
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Enkelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Hypnosis group

Participants in the intervention group will receive a hypnosis session on the day of discharge, a second session seven days post-discharge, and a third session on day 14 if they are still in the hospital. Trained professionals will conduct the hypnosis sessions following a standardized protocol, designed by the study team for critically ill patients.

the hypnosis will be tailored to each patient. Key elements will include relaxation (to mitigate anxiety and stress and help the patient feel more comfortable, secure, and competent), reassociation techniques (to help the patient reconnect with their body, promoting a sense of embodiment and presence), and safe place (to introduce a safe and calming place to instill a sense of control and competence, aiding in emotional stabilization and fostering a sense of safety and well-being).

Ingen indgriben: Control group

Participants in the control group will receive standard post-discharge care, which includes mobilization, nutrition, pain control, and family engagement and empowerment, without any hypnosis intervention.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Wellbeing at day 28 post intensive care unit discharge
Tidsramme: Day 28 post intensive care unit discharge

ESAS scale (Edmonton Symptom Assessment System) with a range from 0 to 100. Higher scores means worse wellbeing.

Day 28 post intensive care unit discharge

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Immediate wellbeing following a hypnosis session
Tidsramme: Day 1 (Day of discharge from ICU), day 7, day 14

1) ESAS scale before and after the hypnosis session performed on Day 1 (ICU discharge), Day 7 and D14

-The ESAS scale (Edmonton Symptom Assessment System) has a range from 0 to 100.

Day 1 (Day of discharge from ICU), day 7, day 14
PDI - Peritraumatic distress inventory
Tidsramme: day 28 post ICU discharge

PDI (Peritraumatic distress index, range: 13-65)

day 28 post ICU discharge
PHQ-9 - Patient Health Questionnaire-9
Tidsramme: Day 28 post intensive care unit discharge and 3 months post intensive care

PHQ-9 (Patient Health Questionnaire-9: range 0-27) will be used to assess depressive symptoms at day 28 and 3 months

Day 28 post intensive care unit discharge and 3 months post intensive care
GAD-7 - Generalized Anxiety Disorder-7
Tidsramme: at day 28 and 3 months post ICU discharge

GAD-7 (Generalized Anxiety Disorder-7, range 0-21) will be used to assess anxiety symptoms at day 28 and 3 months post ICU discharge

at day 28 and 3 months post ICU discharge
IES-R (Impact of event Scale)
Tidsramme: 3 months post intensive care unit discharge. Higher score means more PTSD symptoms.

Range: 0-88

3 months post intensive care unit discharge. Higher score means more PTSD symptoms.
EQ-5D-5L (Quality of life)
Tidsramme: Day 28 post intensive care unit discharge and 3 months post intensive care unit discharge

Part 1) 5 dimensions: Mobility, Self-care, Usual activities, Pain/discomfort, Anxiety/depression. The 5-digit health state is converted (via country-specific value set) to an index value

Part 2) EQ VAS (Visual Analog Scale). Patient rates their health today from 0 to 100.

Higher scores mean better quality of life.

Day 28 post intensive care unit discharge and 3 months post intensive care unit discharge
PGIC - Patient Global Impression of Change
Tidsramme: Day 28 post intensive care unit discharge and 3 months post intensive care unit discharge

Single-item global rating of how much the patient feels their condition has changed since a reference time. Higher scores means improvement.

Scoring / range: 1-7

Day 28 post intensive care unit discharge and 3 months post intensive care unit discharge

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Efterforskere

  • Ledende efterforsker: Hannah Wozniak, Medical Doctor, University Hospital, Geneva
  • Ledende efterforsker: Matteo Coen, MD, PHD, University Hospital, Geneva

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

16. marts 2026

Primær færdiggørelse (Anslået)

1. oktober 2027

Studieafslutning (Anslået)

1. december 2027

Datoer for studieregistrering

Først indsendt

14. november 2025

Først indsendt, der opfyldte QC-kriterier

19. november 2025

Først opslået (Faktiske)

28. november 2025

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

10. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

9. november 2026

Sidst verificeret

1. november 2026

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

UBESLUTET

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner